• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[多发性骨髓瘤所致轻链肾病的预后改善]

[Improved prognosis in light chain nephropathy due to multiple myeloma].

作者信息

Juul Jakob Søgaard, Larsen Thomas, Marcussen Niels, Pedersen Erling Bjerregaard

机构信息

Medicinsk Afdeling, Medicinsk Forskning, Regionshospitalet Holstebro, Denmark.

出版信息

Ugeskr Laeger. 2012 Apr 23;174(17):1159-60.

PMID:22533933
Abstract

A 64 year-old woman with acute renal failure and cast nephropathy due to excessive production of lambda free light chains received chemotherapy (using bortezomib and dexamethason) and haemodialysis with a high cut off-filter. The concentration of free light chains was markedly reduced after a fortnight. Nine months after admission, the patient's kidney function had improved and dialysis was stopped. Three months later, she got an autologous stem cell transplantation. One year later, estimated glomerular filtration rate was 25 ml/min, and the production of free light chains was under control.

摘要

一名64岁女性因λ游离轻链产生过多导致急性肾衰竭和管型肾病,接受了化疗(使用硼替佐米和地塞米松)以及高通量血液透析。两周后游离轻链浓度显著降低。入院九个月后,患者肾功能改善,停止透析。三个月后,她接受了自体干细胞移植。一年后,估计肾小球滤过率为25毫升/分钟,游离轻链产生得到控制。

相似文献

1
[Improved prognosis in light chain nephropathy due to multiple myeloma].[多发性骨髓瘤所致轻链肾病的预后改善]
Ugeskr Laeger. 2012 Apr 23;174(17):1159-60.
2
High cut-off hemodialysis and bortezomib-based therapy to rescue kidneys in myeloma-dependent cast nephropathy.高截留血液透析联合硼替佐米治疗骨髓瘤相关管型肾病。
Am J Hematol. 2012 Jun;87(6):640. doi: 10.1002/ajh.23189. Epub 2012 Mar 31.
3
Successful use of combined high cut-off haemodialysis and bortezomib for acute kidney injury associated with myeloma cast nephropathy.联合使用高通量血液透析和硼替佐米治疗与骨髓瘤管型肾病相关的急性肾损伤取得成功。
Ir Med J. 2012 May;105(5):148-9.
4
[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].[慢性肾脏病合并多发性骨髓瘤患者自体移植后肾功能部分恢复]
Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.
5
Evaluation of blood purification and bortezomib plus dexamethasone therapy for the treatment of acute renal failure due to myeloma cast nephropathy.血液净化联合硼替佐米及地塞米松治疗骨髓瘤管型肾病所致急性肾衰竭的疗效评估
Ther Apher Dial. 2010 Oct;14(5):451-6. doi: 10.1111/j.1744-9987.2010.00863.x.
6
Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.伴有少尿性管型肾病的λ轻链骨髓瘤,经硼替佐米、阿霉素和地塞米松治疗后缓解
JNMA J Nepal Med Assoc. 2012 Oct-Dec;52(188):192-5.
7
Bortezomib successfully reverses early recurrence of light-chain deposition disease in a renal allograft: a case report.硼替佐米成功逆转肾移植中轻链沉积病的早期复发:一例报告
Transplant Proc. 2009 Dec;41(10):4407-10. doi: 10.1016/j.transproceed.2009.10.005.
8
Immunoglobulin free light chain levels and recovery from myeloma kidney on treatment with chemotherapy and high cut-off haemodialysis.免疫球蛋白游离轻链水平和化疗及高截留血液透析治疗骨髓瘤肾病的恢复。
Nephrol Dial Transplant. 2012 Oct;27(10):3823-8. doi: 10.1093/ndt/gfr773. Epub 2012 Jan 23.
9
Myeloma kidney: improving clinical outcomes?多发性骨髓瘤相关性肾病:改善临床结局?
Adv Chronic Kidney Dis. 2012 Sep;19(5):342-51. doi: 10.1053/j.ackd.2012.03.001.
10
[Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].[与单克隆丙种球蛋白病相关的肾脏疾病:诊断与治疗进展]
Presse Med. 2012 Mar;41(3 Pt 1):276-89. doi: 10.1016/j.lpm.2011.11.008. Epub 2012 Jan 13.